New Zealand Allows Clinics To Dose Isotane For Acne
This article was originally published in PharmAsia News
Executive Summary
Skin-care treatment centers in New Zealand moved quickly to take advantage of a decision by the Pharmaceutical Management Agency of New Zealand to allow coverage of broader sales of Pacific Pharmaceuticals' Isotane (isotretinoin). The Skin Institute and others had anticipated PHARMAC's decision to expand the authority to write prescriptions for the anti-acne drug beyond physician offices. The institute, a national skincare chain, had pressed for approving acne clinics to prescribe the drugs, citing equity-of-access issues. (Click here for more